UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data

BMC neurology, 2012-06, Vol.12 (1), p.46-46, Article 46

2012

Volltextzugriff (PDF)

Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform

BMC psychiatry, 2020-07, Vol.20 (1), p.384-384, Article 384

2020

Volltextzugriff (PDF)

Toll-Like Receptor 3 Is a Potent Negative Regulator of Axonal Growth in Mammals

The Journal of neuroscience, 2007-11, Vol.27 (47), p.13033-13041

2007

Volltextzugriff (PDF)

Robotic Measurement of Arm Movements After Stroke Establishes Biomarkers of Motor Recovery

Stroke (1970), 2014-01, Vol.45 (1), p.200-204

2014

Volltextzugriff (PDF)

A register-based approach to identifying treatment-resistant depression—Comparison with clinical definitions

PloS one, 2020, Vol.15 (7), p.e0236434-e0236434

2020

Volltextzugriff (PDF)

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients

PloS one, 2020-09, Vol.15 (9), p.e0238843-e0238843

2020

Volltextzugriff (PDF)

All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population

Annals of general psychiatry, 2019-09, Vol.18 (1), p.23-23, Article 23

2019

Volltextzugriff (PDF)

Accurate prediction of clinical stroke scales and improved biomarkers of motor impairment from robotic measurements

PloS one, 2021-01, Vol.16 (1), p.e0245874-e0245874

2021

Volltextzugriff (PDF)

Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study

BMC psychiatry, 2020-05, Vol.20 (1), p.232-232, Article 232

2020

Volltextzugriff (PDF)

Humanistic outcomes in treatment resistant depression: a secondary analysis of the STARD study

BMC psychiatry, 2018-10, Vol.18 (1), p.352-352, Article 352

2018

Volltextzugriff (PDF)

The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials

Alzheimer's & dementia, 2013-02, Vol.9 (1), p.S21-S31

2013

Volltextzugriff (PDF)

Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine

International journal of methods in psychiatric research, 2022-12, Vol.31 (4), p.e1927-n/a

2022

Volltextzugriff (PDF)

WAVE1 Is Required for Oligodendrocyte Morphogenesis and Normal CNS Myelination

The Journal of neuroscience, 2006-05, Vol.26 (21), p.5849-5859

2006

Volltextzugriff (PDF)

Optimizing regions-of-interest composites for capturing treatment effects on brain amyloid in clinical trials

Journal of Alzheimer's disease, 2015-01, Vol.43 (3), p.809

2015

Volltextzugriff (PDF)

Quantifying the pathophysiological timeline of Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.26 (4), p.745

2011

Volltextzugriff (PDF)

Appraising esketamine nasal spray for the management of treatment-resistant depression in adults: Number needed to treat, number needed to harm, and likelihood to be helped or harmed

Journal of affective disorders, 2020-06, Vol.271, p.228-238

2020

Volltextzugriff (PDF)

Translating preclinical insights into effective human trials in ALS

Biochimica et biophysica acta, 2006-11, Vol.1762 (11), p.1139-1149

2006

Volltextzugriff (PDF)

144 Esketamine Nasal Spray for Management of Treatment-Resistant Depression: Number Needed to Treat, Number Needed to Harm, Likelihood to be Helped/Harmed

CNS spectrums, 2020-04, Vol.25 (2), p.291-292

2020

Volltextzugriff (PDF)

The natural history of brain volume loss among patients with multiple sclerosis: A systematic literature review and meta-analysis

Journal of the neurological sciences, 2015-10, Vol.357 (1), p.8-18

2015

Volltextzugriff (PDF)

Substance use disorders and risk for treatment resistant depression: a population‐based, nested case‐control study

Addiction (Abingdon, England), 2020-04, Vol.115 (4), p.768-777

2020

Volltextzugriff (PDF)

Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden

Journal of affective disorders, 2018-10, Vol.238, p.674-679

2018

Volltextzugriff (PDF)

Treatment‐resistant depression as risk factor for substance use disorders—a nation‐wide register‐based cohort study

Addiction (Abingdon, England), 2019-07, Vol.114 (7), p.1274-1282

2019

Volltextzugriff (PDF)

Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review

Neurological Sciences, 2016-02, Vol.37 (2), p.165-179

2016

Volltextzugriff (PDF)

Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study

Archives of suicide research, 2021-07, Vol.25 (3), p.424-438

2021

Volltextzugriff (PDF)

Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study

Journal of women's health (Larchmont, N.Y. 2002), 2024-04, Vol.33 (4), p.480

2024

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(57)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data

Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform

Toll-Like Receptor 3 Is a Potent Negative Regulator of Axonal Growth in Mammals

Robotic Measurement of Arm Movements After Stroke Establishes Biomarkers of Motor Recovery

A register-based approach to identifying treatment-resistant depression—Comparison with clinical definitions

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients

All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population

Accurate prediction of clinical stroke scales and improved biomarkers of motor impairment from robotic measurements

Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study

Humanistic outcomes in treatment resistant depression: a secondary analysis of the STARD study

The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials

Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine

WAVE1 Is Required for Oligodendrocyte Morphogenesis and Normal CNS Myelination

Optimizing regions-of-interest composites for capturing treatment effects on brain amyloid in clinical trials

Quantifying the pathophysiological timeline of Alzheimer's disease

Appraising esketamine nasal spray for the management of treatment-resistant depression in adults: Number needed to treat, number needed to harm, and likelihood to be helped or harmed

Translating preclinical insights into effective human trials in ALS

144 Esketamine Nasal Spray for Management of Treatment-Resistant Depression: Number Needed to Treat, Number Needed to Harm, Likelihood to be Helped/Harmed

The natural history of brain volume loss among patients with multiple sclerosis: A systematic literature review and meta-analysis

Substance use disorders and risk for treatment resistant depression: a population‐based, nested case‐control study

Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden

Treatment‐resistant depression as risk factor for substance use disorders—a nation‐wide register‐based cohort study

Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review

Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study

Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study

Suchergebnisse filtern